Early social exposure in day care can mitigate stereotyping

Prior research has found that exposure to social diversity in early life, such as through day care, influences how people communicate.

OSE wins French govt grant for Phase III trial for cancer vaccine

Share this article The US Food and Drug Administration (FDA) approved the trial protocol for the registrational Phase III trial for OSE’s Tedopi in January.

April 11, 2024

Pharmalittle: We’re reading about FDA plans to ban a cold med; Eisai Alzheimer’s drug sales, and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

November 8, 2024

IntegriChain acquires pharma advisory services firm FCS

The acquisition marks IntegriChain’s seventh expansion. Credit: Gorodenkoff/Shutterstock. IntegriChain, a provider of data-driven commercialisation solutions for the pharmaceutical industry, has acquired pharma advisory and managed

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.